Related Experiment Videos

Optimum age for measles immunization in Malaysia

Insights

This study in Malaysia found measles infection is common, peaking between 12 months and 5 years. The optimal age for measles immunization was determined to be 11 months for better seroconversion rates.

Area of Science:

  • Immunology
  • Epidemiology
  • Public Health

Background:

  • Measles infection is a significant global health concern.
  • Understanding age-specific prevalence and seroconversion is crucial for effective vaccination strategies.

Purpose of the Study:

  • To determine the age-specific prevalence of measles infection in Malaysia using serology.
  • To assess age-specific seroconversion rates following measles vaccination.
  • To identify the optimal age for measles immunization in the Malaysian context.

Main Methods:

  • Serological testing was employed to assess measles antibody prevalence.
  • Age-specific seroconversion rates post-vaccination were analyzed.
  • Data was collected from a study conducted at the University Hospital, Kuala Lumpur, Malaysia.

Main Results:

  • Passively acquired measles antibodies decreased with age until 3-5 months.
  • Measles infection prevalence increased sharply from 12 months of age.
  • Seroconversion rates after vaccination at 9 months ranged from 94% to 99%, with higher rates observed for vaccination at 11 months or older.

Conclusions:

  • Measles infection is prevalent in Malaysia, with natural infection acquisition peaking between 12 months and 5 years.
  • Vaccination at 11 months or older yields higher seroconversion rates and antibody titers.
  • The optimal age for measles immunization in Malaysia is recommended to be 11 months.

Related Concept Videos